• Kalytera’s Cannabidiol Prevents Graft-Versus-Host-Disease After Bone Marrow Transplant, Data Show
  • CAR T-cell Therapy Combo Shows Promise in Treating Advanced Multiple Myeloma, Study Says
  • Risk of Multiple Myeloma in People with MGUS Can Rise Over Time, Study Finds
  • Evomela Approved as Pre-transplant Conditioning Therapy for Multiple Myeloma Patients in China
  • Triple Therapies Best, But Revlimid with Dexamethasone Could Work in Some Difficult-to-Treat Myelomas, Study Shows
  • ‘Moving Mountains for Multiple Myeloma’ Takes Trek Challenge to Iceland
  • AJMC Introduces 14-part Video Series on Multiple Myeloma Treatment
  • clonoSEQ Assay Approved in New York to Measure MRD in Myeloma, Other Blood Cancers
  • First Patient Dosed in Phase 1 Trial of Antibody for Advanced Multiple Myeloma, Teneobio Announces
  • Tally of Risk Factors Can Identify Myeloma Patients at Risk of Deep-vein Blood Clots, Study Suggests
  • Donor-derived CAR T-cell Therapy ALLO-715 Enters Clinical Testing for Multiple Myeloma
  • CHMP Favors Empliciti Triple Combo to Treat Advanced Multiple Myeloma Patients in EU